Two Sigma Investments’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,362
| Closed | -$61.9K | – | 2976 |
|
|
2024
Q1 | $61.9K | Buy |
+3,362
| New | +$61.9K | ﹤0.01% | 2796 |
|
|
2023
Q4 | – | Sell |
-2,805
| Closed | -$52.9K | – | 3084 |
|
|
2023
Q3 | $52.9K | Sell |
2,805
-8,356
| -75% | -$157K | ﹤0.01% | 2731 |
|
|
2023
Q2 | $252K | Buy |
11,161
+4,486
| +67% | +$101K | ﹤0.01% | 2493 |
|
|
2023
Q1 | $170K | Buy |
+6,675
| New | +$170K | ﹤0.01% | 2515 |
|
|
2022
Q2 | – | Sell |
-1,027
| Closed | -$17K | – | 2490 |
|
|
2022
Q1 | $17K | Sell |
1,027
-11,790
| -92% | -$195K | ﹤0.01% | 2490 |
|
|
2021
Q4 | $326K | Sell |
12,817
-5,850
| -31% | -$149K | ﹤0.01% | 2134 |
|
|
2021
Q3 | $836K | Buy |
18,667
+15,887
| +571% | +$711K | ﹤0.01% | 1773 |
|
|
2021
Q2 | $112K | Sell |
2,780
-7,028
| -72% | -$283K | ﹤0.01% | 2298 |
|
|
2021
Q1 | $522K | Buy |
9,808
+6,321
| +181% | +$336K | ﹤0.01% | 1848 |
|
|
2020
Q4 | $139K | Buy |
3,487
+276
| +9% | +$11K | ﹤0.01% | 1871 |
|
|
2020
Q3 | $183K | Sell |
3,211
-8,272
| -72% | -$471K | ﹤0.01% | 1692 |
|
|
2020
Q2 | $847K | Buy |
11,483
+4,323
| +60% | +$319K | ﹤0.01% | 1218 |
|
|
2020
Q1 | $355K | Buy |
7,160
+3,816
| +114% | +$189K | ﹤0.01% | 1373 |
|
|
2019
Q4 | $257K | Buy |
+3,344
| New | +$257K | ﹤0.01% | 1914 |
|
|
2019
Q2 | – | Sell |
-840
| Closed | -$45K | – | 2090 |
|
|
2019
Q1 | $45K | Sell |
840
-627
| -43% | -$33.6K | ﹤0.01% | 2041 |
|
|
2018
Q4 | $69K | Buy |
1,467
+721
| +97% | +$33.9K | ﹤0.01% | 1986 |
|
|
2018
Q3 | $66K | Buy |
+746
| New | +$66K | ﹤0.01% | 1935 |
|